Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 279

1.

Addressing the burden of illness in adults with cystic fibrosis with screening and triage: An early intervention model of palliative care.

Dhingra L, Walker P, Berdella M, Plachta A, Chen J, Fresenius A, Balzano J, Barrett M, Bookbinder M, Wilder K, Glajchen M, Langfelder-Schwind E, Portenoy RK.

J Cyst Fibros. 2019 Aug 27. pii: S1569-1993(19)30841-0. doi: 10.1016/j.jcf.2019.08.009. [Epub ahead of print]

PMID:
31471264
2.

Defining Core Competencies for Generalist-Level Palliative Social Work.

Glajchen M, Berkman C, Otis-Green S, Stein GL, Sedgwick T, Bern-Klug M, Christ G, Csikai E, Downes D, Gerbino S, Head B, Parker-Oliver D, Waldrop D, Portenoy RK.

J Pain Symptom Manage. 2018 Dec;56(6):886-892. doi: 10.1016/j.jpainsymman.2018.09.002. Epub 2018 Sep 7.

PMID:
30201485
3.

Pain-related distress among patients referred to a community-based palliative care program.

Riggs A, Breuer B, Patel V, Harounian J, Chen J, Dhingra L, Portenoy RK, Knotkova H.

Palliat Support Care. 2019 Jun;17(3):338-344. doi: 10.1017/S1478951518000251. Epub 2018 Jun 26.

PMID:
29941065
4.

At-Home Transcranial Direct Current Stimulation (tDCS) With Telehealth Support for Symptom Control in Chronically-Ill Patients With Multiple Symptoms.

Riggs A, Patel V, Paneri B, Portenoy RK, Bikson M, Knotkova H.

Front Behav Neurosci. 2018 May 22;12:93. doi: 10.3389/fnbeh.2018.00093. eCollection 2018.

5.

Cancer Pain Syndromes.

Portenoy RK, Ahmed E.

Hematol Oncol Clin North Am. 2018 Jun;32(3):371-386. doi: 10.1016/j.hoc.2018.01.002. Epub 2018 Mar 22. Review.

PMID:
29729775
6.

Web-Based Cognitive Behavior Therapy for Chronic Pain Patients with Aberrant Drug-Related Behavior: Outcomes from a Randomized Controlled Trial.

Guarino H, Fong C, Marsch LA, Acosta MC, Syckes C, Moore SK, Cruciani RA, Portenoy RK, Turk DC, Rosenblum A.

Pain Med. 2018 Dec 1;19(12):2423-2437. doi: 10.1093/pm/pnx334.

PMID:
29346579
7.

Trajectories of caregiver burden in families of adult cystic fibrosis patients.

Wojtaszczyk A, Glajchen M, Portenoy RK, Berdella M, Walker P, Barrett M, Chen J, Plachta A, Balzano J, Fresenius A, Wilder K, Langfelder-Schwind E, Dhingra L.

Palliat Support Care. 2018 Dec;16(6):732-740. doi: 10.1017/S1478951517000918. Epub 2017 Oct 17.

PMID:
29037271
8.

Development and Field Test of an Audit Tool and Tracer Methodology for Clinician Assessment of Quality in End-of-Life Care.

Bookbinder M, Hugodot A, Freeman K, Homel P, Santiago E, Riggs A, Gavin M, Chu A, Brady E, Lesage P, Portenoy RK.

J Pain Symptom Manage. 2018 Feb;55(2):207-216.e2. doi: 10.1016/j.jpainsymman.2017.08.017. Epub 2017 Aug 26.

PMID:
28844623
9.

Hospice Enrollment After Referral to Community-Based, Specialist Palliative Care: Impact of Telephonic Outreach.

Riggs A, Breuer B, Dhingra L, Chen J, Portenoy RK, Knotkova H.

J Pain Symptom Manage. 2017 Aug;54(2):219-225. doi: 10.1016/j.jpainsymman.2017.03.007. Epub 2017 Apr 24.

PMID:
28450217
10.

Repurposing Medications for Hospice/Palliative Care Symptom Control Is No Longer Sufficient: A Manifesto for Change.

Currow DC, Abernethy AP, Fallon M, Portenoy RK.

J Pain Symptom Manage. 2017 Mar;53(3):533-539. doi: 10.1016/j.jpainsymman.2016.10.358. Epub 2016 Dec 30.

PMID:
28042066
11.

Breakthrough cancer pain: twenty-five years of study.

Mercadante S, Portenoy RK.

Pain. 2016 Dec;157(12):2657-2663.

PMID:
27653423
12.

Hospice Enrollment After Referral to Community-Based, Specialist-Level Palliative Care: Incidence, Timing, and Predictors.

Riggs A, Breuer B, Dhingra L, Chen J, Hiney B, McCarthy M, Portenoy RK, Knotkova H.

J Pain Symptom Manage. 2016 Aug;52(2):170-7. doi: 10.1016/j.jpainsymman.2016.02.011. Epub 2016 May 18.

PMID:
27208866
13.

Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication.

Nikulina V, Guarino H, Acosta MC, Marsch LA, Syckes C, Moore SK, Portenoy RK, Cruciani RA, Turk DC, Rosenblum A.

Pain. 2016 Aug;157(8):1791-8. doi: 10.1097/j.pain.0000000000000583.

14.

Web-based symptom screening in cystic fibrosis patients: A feasibility study.

Balzano J, Fresenius A, Walker P, Berdella M, Portenoy RK, Bookbinder M, Glajchen M, Plachta A, Langfelder-Schwind E, Chen J, Dhingra L.

J Cyst Fibros. 2016 Jan;15(1):102-8. doi: 10.1016/j.jcf.2015.11.001. Epub 2015 Nov 21.

15.

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.

Kutner JS, Blatchford PJ, Taylor DH Jr, Ritchie CS, Bull JH, Fairclough DL, Hanson LC, LeBlanc TW, Samsa GP, Wolf S, Aziz NM, Currow DC, Ferrell B, Wagner-Johnston N, Zafar SY, Cleary JF, Dev S, Goode PS, Kamal AH, Kassner C, Kvale EA, McCallum JG, Ogunseitan AB, Pantilat SZ, Portenoy RK, Prince-Paul M, Sloan JA, Swetz KM, Von Gunten CF, Abernethy AP.

JAMA Intern Med. 2015 May;175(5):691-700. doi: 10.1001/jamainternmed.2015.0289. Erratum in: JAMA Intern Med. 2015 May;175(5):869. Erratum in: JAMA Intern Med. 2019 Jan 1;179(1):126-127.

16.

Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance.

Dhingra L, Perlman DC, Masson C, Chen J, McKnight C, Jordan AE, Wasser T, Portenoy RK, Cheatle MD.

Drug Alcohol Depend. 2015 Apr 1;149:285-9. doi: 10.1016/j.drugalcdep.2015.02.007. Epub 2015 Feb 17.

17.

National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomes.

Narayana A, Katz N, Shillington AC, Stephenson JJ, Harshaw Q, Frye CB, Portenoy RK.

Pain. 2015 Feb;156(2):252-9. doi: 10.1097/01.j.pain.0000460305.41078.7d.

PMID:
25599446
18.

How well do medical oncologists manage chronic cancer pain? A national survey.

Breuer B, Chang VT, Von Roenn JH, von Gunten C, Neugut AI, Kaplan R, Wallenstein S, Portenoy RK.

Oncologist. 2015 Feb;20(2):202-9. doi: 10.1634/theoncologist.2014-0276. Epub 2015 Jan 12.

19.

Principles of opioid use in cancer pain.

Portenoy RK, Ahmed E.

J Clin Oncol. 2014 Jun 1;32(16):1662-70. doi: 10.1200/JCO.2013.52.5188. Epub 2014 May 5. Review.

PMID:
24799466
20.

Risks associated with opioid use.

Portenoy RK.

JAMA. 2013 Oct 23;310(16):1738. doi: 10.1001/jama.2013.277291. No abstract available.

PMID:
24150476
21.

Transient thermal sympathectomy as a possible mechanism for hypotension after kyphoplasty: a case report.

Soto E, Galperin M, Portenoy RK.

Clin J Pain. 2013 Dec;29(12):e49-53. doi: 10.1097/AJP.0000000000000031.

PMID:
24042346
22.

Transcranial direct current stimulation (tDCS) relieved itching in a patient with chronic neuropathic pain.

Knotkova H, Portenoy RK, Cruciani RA.

Clin J Pain. 2013 Jul;29(7):621-2. doi: 10.1097/AJP.0b013e31826b1329.

PMID:
23328331
23.

Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.

Rosenblum A, Cruciani RA, Strain EC, Cleland CM, Joseph H, Magura S, Marsch LA, McNicholas LF, Savage SR, Sundaram A, Portenoy RK.

J Opioid Manag. 2012 Nov-Dec;8(6):369-82. doi: 10.5055/jom.2012.0137.

24.

Epidemiology of pain among outpatients in methadone maintenance treatment programs.

Dhingra L, Masson C, Perlman DC, Seewald RM, Katz J, McKnight C, Homel P, Wald E, Jordan AE, Young C, Portenoy RK.

Drug Alcohol Depend. 2013 Feb 1;128(1-2):161-5. doi: 10.1016/j.drugalcdep.2012.08.003. Epub 2012 Aug 27.

25.

Spiritual well-being in patients with advanced heart and lung disease.

Strada EA, Homel P, Tennstedt S, Billings JA, Portenoy RK.

Palliat Support Care. 2013 Jun;11(3):205-13. doi: 10.1017/S1478951512000065. Epub 2012 Jul 30.

PMID:
22840215
26.

Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.

Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, McQuade R, Wright S, Fallon MT.

J Pain. 2012 May;13(5):438-49. doi: 10.1016/j.jpain.2012.01.003. Epub 2012 Apr 5.

PMID:
22483680
27.
28.

Medical oncologists' attitudes and practice in cancer pain management: a national survey.

Breuer B, Fleishman SB, Cruciani RA, Portenoy RK.

J Clin Oncol. 2011 Dec 20;29(36):4769-75. doi: 10.1200/JCO.2011.35.0561. Epub 2011 Nov 14.

PMID:
22084372
29.

Treatment of cancer pain.

Portenoy RK.

Lancet. 2011 Jun 25;377(9784):2236-47. doi: 10.1016/S0140-6736(11)60236-5. Review.

PMID:
21704873
30.

A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group.

Abernethy AP, Aziz NM, Basch E, Bull J, Cleeland CS, Currow DC, Fairclough D, Hanson L, Hauser J, Ko D, Lloyd L, Morrison RS, Otis-Green S, Pantilat S, Portenoy RK, Ritchie C, Rocker G, Wheeler JL, Zafar SY, Kutner JS.

J Palliat Med. 2010 Dec;13(12):1407-13. doi: 10.1089/jpm.2010.0261. Epub 2010 Nov 24.

31.

Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients.

Portenoy RK, Raffaeli W, Torres LM, Sitte T, Deka AC, Herrera IG, Wallace MS; Fentanyl Nasal Spray Study 045 Investigators Group.

J Opioid Manag. 2010 Sep-Oct;6(5):319-28. Erratum in: J Opioid Manag. 2010 Nov-Dec;6(6):407. J Opioid Manag. 2011 Jan-Feb;7(1):26.

PMID:
21046929
32.

Nurse practitioner-based models of specialist palliative care at home: sustainability and evaluation of feasibility.

Bookbinder M, Glajchen M, McHugh M, Higgins P, Budis J, Solomon N, Homel P, Cassin C, Portenoy RK.

J Pain Symptom Manage. 2011 Jan;41(1):25-34. doi: 10.1016/j.jpainsymman.2010.04.011. Epub 2010 Sep 19.

PMID:
20851569
33.

Protect your patients, protect your practice: practical risk assessment in the structuring of opioid therapy in chronic pain.

Fine PG, Finnegan T, Portenoy RK.

J Fam Pract. 2010 Sep;59(9 Suppl 2):S1-16. No abstract available.

PMID:
20824240
34.
35.

A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain.

Portenoy RK, Burton AW, Gabrail N, Taylor D; Fentanyl Pectin Nasal Spray 043 Study Group.

Pain. 2010 Dec;151(3):617-24. doi: 10.1016/j.pain.2010.07.028. Epub 2010 Aug 25.

PMID:
20800358
36.

Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey.

Breuer B, Cruciani R, Portenoy RK.

South Med J. 2010 Aug;103(8):738-47. doi: 10.1097/SMJ.0b013e3181e74ede.

PMID:
20622716
37.

Recent advances in the treatment of cancer pain.

Portenoy RK.

Clin Adv Hematol Oncol. 2010 Apr;8(4):272-4. No abstract available.

PMID:
20505650
38.

Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life.

Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA.

J Opioid Manag. 2010 Mar-Apr;6(2):109-16.

PMID:
20481175
39.

Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics.

Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA.

J Opioid Manag. 2010 Mar-Apr;6(2):97-108.

PMID:
20481174
40.

New opioids: expensive distractions or important additions to practice?

von Gunten CF, Bruera E, Pirrello RD, Portenoy RK.

J Palliat Med. 2010 May;13(5):505-11. doi: 10.1089/jpm.2010.9815. Review. No abstract available.

PMID:
20406105
41.

Opioid rotation: the science and the limitations of the equianalgesic dose table.

Knotkova H, Fine PG, Portenoy RK.

J Pain Symptom Manage. 2009 Sep;38(3):426-39. doi: 10.1016/j.jpainsymman.2009.06.001. Review.

PMID:
19735903
42.

Establishing "best practices" for opioid rotation: conclusions of an expert panel.

Fine PG, Portenoy RK; Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation.

J Pain Symptom Manage. 2009 Sep;38(3):418-25. doi: 10.1016/j.jpainsymman.2009.06.002.

43.

Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease.

Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK.

J Pain Symptom Manage. 2009 Jul;38(1):115-23. doi: 10.1016/j.jpainsymman.2008.07.006. Epub 2009 Feb 20.

PMID:
19232893
44.
45.

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel.

J Pain. 2009 Feb;10(2):113-30. doi: 10.1016/j.jpain.2008.10.008.

46.

JPSM affiliates with the AAHPM.

Portenoy RK.

J Pain Symptom Manage. 2009 Jan;37(1):1-2. doi: 10.1016/j.jpainsymman.2008.11.001. No abstract available.

PMID:
19111777
47.

Education and training.

Chamberlain B, Portenoy RK.

J Palliat Med. 2008 Nov;11(9):1180-1. doi: 10.1089/jpm.2008.9834. No abstract available.

PMID:
19021473
48.

Palliative medicine: from paradigm to best practice.

Portenoy RK.

J Palliat Med. 2008 Oct;11(8):1092-3. doi: 10.1089/jpm.2008.9867. No abstract available.

PMID:
18980449
49.

Opioids and the treatment of chronic pain: controversies, current status, and future directions.

Rosenblum A, Marsch LA, Joseph H, Portenoy RK.

Exp Clin Psychopharmacol. 2008 Oct;16(5):405-16. doi: 10.1037/a0013628. Review.

50.

L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study.

Cruciani RA, Dvorkin E, Homel P, Culliney B, Malamud S, Lapin J, Portenoy RK, Esteban-Cruciani N.

J Pain Symptom Manage. 2009 Apr;37(4):622-31. doi: 10.1016/j.jpainsymman.2008.03.021. Epub 2008 Sep 21.

PMID:
18809275

Supplemental Content

Loading ...
Support Center